Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide, Dexamethasone, and Clarithromycin Maintenance for Multiple Myeloma
NCT00182663Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jun 2003
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clarithromycin, thalidomide in multiple myeloma (MM), sponsored by Fred Hutchinson Cancer Center. Started Jun 2003; status: completed.
02
Drugs
clarithromycinthalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00182663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182663.